14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
14th European Congress of Clinical Microbiology and Infectious ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Scientific Programme Monday, May 3, 2004<br />
O256 Utility <strong>of</strong> the 750 mg dose <strong>of</strong> lev<strong>of</strong>loxacin<br />
14:24 against Streptococcus pneumoniae as<br />
assessed by Monte Carlo simulation <strong>and</strong><br />
expectation over a large MIC distribution<br />
G. Drusano, E. Grant (Albany, Raritan, USA)<br />
O257 Use <strong>of</strong> pharmacodynamics <strong>and</strong> Monte Carlo<br />
14:36 simulations to predict clinical cure <strong>of</strong><br />
Pseudomonas aeruginosa infection<br />
S. Valot, M. Etienne, D. Croisier, L. Piroth,<br />
H. Portier, P. Chavanet (Dijon, F)<br />
O258 Development <strong>of</strong> a pharmacokinetic/<br />
14:48 pharmacodynamic model to characterise<br />
the in vitro activity <strong>and</strong> dose-response<br />
relationships <strong>of</strong> daptomycin <strong>and</strong> linezolid<br />
against Vancomycin-Resistant Enterococci<br />
(VRE) using subpopulation analysis<br />
S. Bajic, B.M. Booker, P. Kelchlin, A. Forrest,<br />
P.F. Smith (Buffalo, USA)<br />
Small<br />
Hall<br />
Official Symposia<br />
Antibiotic resistance, prevention <strong>and</strong> control<br />
in Europe<br />
Chairpersons: Ian Gould (Aberdeen, UK)<br />
Herman Goossens (Antwerp, B)<br />
S259 Epidemiology <strong>of</strong> antibiotic resistance across<br />
15:30 Europe<br />
Herman Goossens (Antwerp, B)<br />
S260 Antibiotic policies <strong>and</strong> consumption in<br />
16:00 <strong>European</strong> hospitals<br />
Fiona MacKenzie (Aberdeen, UK)<br />
S261 Infection control policies in <strong>European</strong> hospitals<br />
16:30 Marc Struelens (Brussels, B)<br />
S262 Molecular typing to control antibiotic resistance<br />
17:00 Kevin Towner (Nottingham, UK)<br />
Official symposium arranged with the Antibiotic<br />
Resistance – Prevention <strong>and</strong> Control Steering<br />
Group (ARPAC)<br />
Panorama<br />
Hall<br />
Group A streptococcal disease in the<br />
21 st century<br />
Chairpersons: Claes Schalén (Lund, S)<br />
Paula Kriz (Prague, CZ)<br />
S263 Strep-EURO project: progress report<br />
15:30 Aftab Jasir (Lund, S)<br />
S264 Severe group A streptococcal infections in<br />
16:00 Europe: microbiological <strong>and</strong> epidemiological<br />
aspects<br />
Androulla Efstratiou (London, UK)<br />
S265 Multilocus sequence typing <strong>of</strong> group A<br />
16:30 streptococci in invasive infections<br />
Paula Kriz (Prague, CZ)<br />
S266 Pathogenic aspects on severe group A<br />
17:00 streptococcal infections<br />
Claes Schalén (Lund, S)<br />
Forum<br />
Hall<br />
Lyme borreliosis<br />
Chairpersons: Gerold Stanek (Vienna, A)<br />
Jiri Beran (Hradec Kralove, CZ)<br />
S267 Biology <strong>of</strong> Borrelia <strong>and</strong> epidemiology <strong>of</strong> disease<br />
15:30 Gerold Stanek (Vienna, A)<br />
S268 Acute <strong>and</strong> chronic manifestations<br />
16:00 Franc Strle (Ljubljana, SI)<br />
S269 The use <strong>and</strong> misuse <strong>of</strong> diagnostic tools<br />
16:30 Henrik Nielsen (Aarborg, DK)<br />
S270 Treatment <strong>and</strong> prevention<br />
17:00 Gary Wormser (New York, USA)<br />
South<br />
Hall<br />
Susceptibility testing <strong>and</strong> its role in therapy<br />
<strong>and</strong> epidemiology<br />
Chairpersons: Gunnar Kahlmeter (Växjö, S)<br />
Derek Brown (Cambridge, UK)<br />
S271 Susceptibility testing <strong>of</strong> bacteria –<br />
15:30 do breakpoints predict therapeutic outcome?<br />
Johan W. Mouton (Nijmegen, NL)<br />
S272 Susceptibility testing <strong>of</strong> fungi –<br />
16:00 do breakpoints predict therapeutic outcome?<br />
J. Peter Donnelly (Nijmegen, NL)<br />
www.escmid.org/eccmid2004 page 51
Change language